Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Activation of Complement: A Potent Biomarker in Multiple Sclerosis Publisher



Sadeghmousavi S1, 2 ; Rezaei N2, 3, 4
Authors

Source: Translational Neuroimmunology: Multiple Sclerosis: Volume 8 Published:2023


Abstract

Multiple sclerosis (MS) is an autoimmune inflammatory disorder of the central nervous system (CNS), which is caused by demyelination, axonal damage, and plaque formation within the CNS. The interaction of inflammatory mediators results in MS pathogenesis and, consequently, neurological deficits. One of the involved inflammatory components is complement. It has been suggested that induced progressive inflammation caused by complement leads to cell and myelin damage, microglial activation, and chemoattraction. The objective of this chapter is to review the literature concerning complement activation in MS, which can help in comprehending the role of complement in MS and thus in designing therapeutic approaches to target complement and control this autoimmune disorder. © 2023 Elsevier Inc. All rights reserved.
Related Docs
View other Related Docs
1. Convergent Effects of a Functional C3 Variant on Brain Atrophy, Demyelination, and Cognitive Impairment in Multiple Sclerosis, Multiple Sclerosis Journal (2019)
2. Immune-Mediated Cognition Impairment in Multiple Sclerosis, Translational Neuroimmunology: Multiple Sclerosis: Volume 8 (2023)
3. Multiple Sclerosis Pathogenesis: Missing Pieces of an Old Puzzle, Reviews in the Neurosciences (2019)
Experts (# of related papers)
View all Related Experts
Mohammad Ali Sahraian (4)
Amirreza Azimi (2)
Other Related Docs
4. The Immunomodulatory Effects of All-Trans Retinoic Acid and Docosahexaenoic Acid Combination Treatment on the Expression of Il-2, Il-4, T-Bet, and Gata3 Genes in Pbmcs of Multiple Sclerosis Patients, Neurological Research (2023)
5. Immunomodulatory Characteristics of Mesenchymal Stem Cells and Their Role in the Treatment of Multiple Sclerosis, Cellular Immunology (2015)
6. The Role of Glycogen Synthase Kinase 3 Beta in Multiple Sclerosis, Biomedicine and Pharmacotherapy (2020)
7. Immunopathogenesis of Multiple Sclerosis: Molecular and Cellular Mechanisms and New Immunotherapeutic Approaches, Immunopharmacology and Immunotoxicology (2024)
8. From Multiple Sclerosis to Organ-Specific Autoimmune Disorders: Insights Into the Molecular and Clinical Implications of Comorbidity, Molecular Neurobiology (2025)
9. Soluble Cd40 Ligand Derived From Serum Is Not Correlated With Early Ms, Multiple Sclerosis and Related Disorders (2017)
10. Trifluoperazine Reduces Cuprizone-Induced Demyelination Via Targeting Nrf2 and Ikb in Mice, European Journal of Pharmacology (2021)
11. The Effect of Microglial Ablation and Mesenchymal Stem Cell Transplantation on a Cuprizone-Induced Demyelination Model, Journal of Cellular Physiology (2021)
12. The Potential Role of T Helper Cell 22 and Il-22 in Immunopathogenesis of Multiple Sclerosis, Innovations in Clinical Neuroscience (2016)
13. Exosomes Derived From Mesenchymal Stem Cells: Heralding a New Treatment for Periodontitis?, Tissue and Cell (2023)
14. New Therapeutic Approach by G2013 in Experimental Model of Multiple Sclerosis, Acta Neurologica Belgica (2015)
15. Leukocyte Gene Expression and Plasma Concentration in Multiple Sclerosis: Alteration of Transforming Growth Factor-Βs, Claudin-11, and Matrix Metalloproteinase-2, Cellular and Molecular Neurobiology (2016)
16. Quantitative Evaluation of Baff, Hmgb1, Tlr 4 and Tlr 7 Expression in Patients With Relapsing Remitting Multiple Sclerosis, Iranian Journal of Allergy# Asthma and Immunology (2016)
17. Air Pollution and Multiple Sclerosis: A Comprehensive Review, Neurological Sciences (2021)
18. Redox Imbalance in Cd4+ T Cells of Relapsing-Remitting Multiple Sclerosis Patients, Oxidative Medicine and Cellular Longevity (2020)
19. Effect of Mesenchymal Stem Cells on Glial Cells Population in Cuprizone Induced Demyelination Model, Neuropeptides (2019)
20. Introducing Radiomics Model to Predict Active Plaque in Multiple Sclerosis Patients Using Magnetic Resonance Images, Biomedical Physics and Engineering Express (2023)